Kubicki S, Herrmann W M, Fichte K, Freund G
Pharmakopsychiatr Neuropsychopharmakol. 1979 Mar;12(2):237-45. doi: 10.1055/s-0028-1094615.
A critical analysis of quantitative pharmaco-electroencephalography begins with parametrization into variables. The determination of frequency bands according to clinical criteria should be reconsidered. Alternatives may be the determination of factor scores or the definition of frequency bands based on factor analysis. If the latter procedure is used, the clinical alpha-band is subdivided into a lower (alpha 1F = 8,5-10.5 HZ) and an upper (alpha 2F = 10.5-12.5 HZ) part. Furthermore parts of the clinical theta-band (and the delta-band are combined into the delta F-band (1.5-6.0 HZ), for awake healthy volunteers with an occipital alpha-rhythm. Existing concepts of vigilance for the awake stages are not contradictory to the following observations: the factor structure of EEG relative power spectrum variables shows a negative correlation of slow alpha-frequencies with those in the delta F- and beta 3F-band. There is also a negative correlation between slow and fast alpha-wave relative power values.
对定量药物脑电图的批判性分析始于将其参数化为变量。应重新考虑根据临床标准确定频段的方法。替代方法可以是确定因子得分或基于因子分析定义频段。如果采用后一种方法,临床α频段可细分为较低部分(α1F = 8.5 - 10.5赫兹)和较高部分(α2F = 10.5 - 12.5赫兹)。此外,对于有枕部α节律的清醒健康志愿者,临床θ频段的部分(以及δ频段)被合并为δF频段(1.5 - 6.0赫兹)。现有关于清醒阶段警觉性的概念与以下观察结果并不矛盾:脑电图相对功率谱变量的因子结构显示,慢α频率与δF频段和β3F频段的频率呈负相关。慢α波和快α波的相对功率值之间也存在负相关。